182 related articles for article (PubMed ID: 8144391)
1. Detection of guanine-C8-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine adduct as a single spot on thin-layer chromatography by modification of the 32P-postlabeling method.
Fukutome K; Ochiai M; Wakabayashi K; Watanabe S; Sugimura T; Nagao M
Jpn J Cancer Res; 1994 Feb; 85(2):113-7. PubMed ID: 8144391
[TBL] [Abstract][Full Text] [Related]
2. 32-P-HPLC analysis of DNA adducts formed in vitro and in vivo by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline, utilizing an improved adduct enrichment procedure.
Wohlin P; Zeisig M; Gustafsson JA; Möller L
Chem Res Toxicol; 1996 Sep; 9(6):1050-6. PubMed ID: 8870995
[TBL] [Abstract][Full Text] [Related]
3. Identification of N-(Deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine as the major adduct formed by the food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, with DNA.
Lin D; Kaderlik KR; Turesky RJ; Miller DW; Lay JO; Kadlubar FF
Chem Res Toxicol; 1992; 5(5):691-7. PubMed ID: 1446011
[TBL] [Abstract][Full Text] [Related]
4. Improved high-performance liquid chromatography analysis of 32P-postlabeled 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-DNA adducts using in-line precolumn purification.
Mauthe RJ; Marsch GA; Turteltaub KW
J Chromatogr B Biomed Appl; 1996 Apr; 679(1-2):91-101. PubMed ID: 8998575
[TBL] [Abstract][Full Text] [Related]
5. Novel LC-ESI/MS/MS(n) method for the characterization and quantification of 2'-deoxyguanosine adducts of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by 2-D linear quadrupole ion trap mass spectrometry.
Goodenough AK; Schut HA; Turesky RJ
Chem Res Toxicol; 2007 Feb; 20(2):263-76. PubMed ID: 17305409
[TBL] [Abstract][Full Text] [Related]
6. 32P-postlabeling analysis of IQ, MeIQx and PhIP adducts formed in vitro in DNA and polynucleotides and found in vivo in hepatic DNA from IQ-, MeIQx- and PhIP-treated monkeys.
Snyderwine EG; Davis CD; Nouso K; Roller PP; Schut HA
Carcinogenesis; 1993 Jul; 14(7):1389-95. PubMed ID: 8330355
[TBL] [Abstract][Full Text] [Related]
7. Mutation and repair induced by the carcinogen 2-(hydroxyamino)-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP) in the dihydrofolate reductase gene of Chinese hamster ovary cells and conformational modeling of the dG-C8-PhIP adduct in DNA.
Carothers AM; Yuan W; Hingerty BE; Broyde S; Grunberger D; Snyderwine EG
Chem Res Toxicol; 1994; 7(2):209-18. PubMed ID: 8199311
[TBL] [Abstract][Full Text] [Related]
8. 32P-post-labelling analysis of DNA adducts formed by food-derived heterocyclic amines: evidence for incomplete hydrolysis and a procedure for adduct pattern simplification.
Pfau W; Brockstedt U; Söhren KD; Marquardt H
Carcinogenesis; 1994 May; 15(5):877-82. PubMed ID: 8200090
[TBL] [Abstract][Full Text] [Related]
9. Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rat extrahepatic tissues.
Kaderlik KR; Minchin RF; Mulder GJ; Ilett KF; Daugaard-Jenson M; Teitel CH; Kadlubar FF
Carcinogenesis; 1994 Aug; 15(8):1703-9. PubMed ID: 8055652
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic DNA adducts formed in vitro and in vivo by the food mutagens 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 2-amino-3-methyl-9H-pyrido[2,3-b]indole (MeA alphaC).
Pfau W; Brockstedt U; Shirai T; Ito N; Marquardt H
Mutat Res; 1997 Aug; 378(1-2):13-22. PubMed ID: 9288881
[TBL] [Abstract][Full Text] [Related]
11. Use of the 32P-postlabeling method to detect DNA adducts of 2-amino-3-methylimidazolo[4,5-f]quinoline (IQ) in monkeys fed IQ: identification of the N-(deoxyguanosin-8-yl)-IQ adduct.
Snyderwine EG; Yamashita K; Adamson RH; Sato S; Nagao M; Sugimura T; Thorgeirsson SS
Carcinogenesis; 1988 Oct; 9(10):1739-43. PubMed ID: 3168152
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard.
Beland FA; Doerge DR; Churchwell MI; Poirier MC; Schoket B; Marques MM
Chem Res Toxicol; 1999 Jan; 12(1):68-77. PubMed ID: 9894020
[TBL] [Abstract][Full Text] [Related]
13. Detection and quantitation of N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine adducts in DNA using online column-switching liquid chromatography tandem mass spectrometry.
Singh R; Arlt VM; Henderson CJ; Phillips DH; Farmer PB; Gamboa da Costa G
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Aug; 878(23):2155-62. PubMed ID: 20598652
[TBL] [Abstract][Full Text] [Related]
14. Determination of in vitro formed DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine using capillary liquid chromatography/electrospray ionization/tandem mass spectrometry.
Rindgen D; Turesky RJ; Vouros P
Chem Res Toxicol; 1995 Dec; 8(8):1005-13. PubMed ID: 8605282
[TBL] [Abstract][Full Text] [Related]
15. Effect of N-acetyltransferase 2 polymorphism on tumor target tissue DNA adduct levels in rapid and slow acetylator congenic rats administered 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine or 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline.
Metry KJ; Neale JR; Bendaly J; Smith NB; Pierce WM; Hein DW
Drug Metab Dispos; 2009 Nov; 37(11):2123-6. PubMed ID: 19666988
[TBL] [Abstract][Full Text] [Related]
16. Effect of glutathione depletion and inhibition of glucuronidation and sulfation on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism, PhIP-DNA adduct formation and unscheduled DNA synthesis in primary rat hepatocytes.
Kaderlik KR; Mulder GJ; Shaddock JG; Casciano DA; Teitel CH; Kadlubar FF
Carcinogenesis; 1994 Aug; 15(8):1711-6. PubMed ID: 8055653
[TBL] [Abstract][Full Text] [Related]
17. Analysis of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine in rat and human tissues by alkaline hydrolysis and gas chromatography/electron capture mass spectrometry: validation by comparison with 32P-postlabeling.
Friesen MD; Kaderlik K; Lin D; Garren L; Bartsch H; Lang NP; Kadlubar FF
Chem Res Toxicol; 1994; 7(6):733-9. PubMed ID: 7696526
[TBL] [Abstract][Full Text] [Related]
18. Identification of N-(deoxyguanosin-8-yl)-2-amino-3,4-dimethylimidazo[4,5-f]quinoline (dG-C8-MeIQ) as a major adduct formed by MeIQ with nucleotides in vitro with DNA in vivo.
Tada A; Ochiai M; Wakabayashi K; Nukaya H; Sugimura T; Nagao M
Carcinogenesis; 1994 Jun; 15(6):1275-8. PubMed ID: 8020167
[TBL] [Abstract][Full Text] [Related]
19. Mutagenesis of the N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine DNA adduct in mammalian cells. Sequence context effects.
Shibutani S; Fernandes A; Suzuki N; Zhou L; Johnson F; Grollman AP
J Biol Chem; 1999 Sep; 274(39):27433-8. PubMed ID: 10488075
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity, DNA adduct formation and DNA repair induced by 2-hydroxyamino-3-methylimidazo[4,5-f]quinoline and 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine in cultured human mammary epithelial cells.
Fan L; Schut HA; Snyderwine EG
Carcinogenesis; 1995 Apr; 16(4):775-9. PubMed ID: 7728954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
